SCHEDULE: Major Shareholder Divests Innovative Eyewear Stake
Schedule 13D Amendment
Vladimir and Angelica Galkin are liquidating their remaining 16.0% stake in Innovative Eyewear Inc, citing unattractive business prospects.
Summary
- Vladimir and Angelica Galkin (Reporting Persons) filed Amendment No. 8 to their Schedule 13D for Innovative Eyewear Inc.
- They currently beneficially own 796,007 shares of Common Stock, representing 16.0% of the Issuer's outstanding shares.
- This percentage is based on 5,350,183 shares outstanding as of November 6, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q.
- Since their last filing (Amendment No. 7 on December 12, 2025), they sold approximately 2.7% of the Issuer's outstanding Common Stock through open market transactions, totaling 142,763 shares.
- The total shares sold by the Reporting Persons between December 4, 2025, and December 26, 2025, amounted to 204,993 shares at volume-weighted average prices ranging from $1.22 to $1.58 per share.
- The Reporting Persons no longer consider Innovative Eyewear Inc. an attractive investment due to its business prospects and strategy.
- They intend to divest their remaining shares in open market transactions over the next six months, marking a change in their investment purpose.
- The Reporting Persons do not expect to have further communications with the company's board, management, or other shareholders regarding operational, strategic, financial, or governance matters.
Sentiment
Score: 2
Explanation: The filing indicates a strong negative sentiment from a significant shareholder who is liquidating their entire position due to a stated lack of confidence in the company's business prospects and strategy.
Negatives
- A significant shareholder, Vladimir and Angelica Galkin, no longer views Innovative Eyewear Inc. as an attractive investment.
- The Reporting Persons intend to fully divest their remaining 16.0% stake (796,007 shares) in the company over the next six months.
- This decision is based on a negative assessment of the Issuer's business prospects and strategy.
- The Reporting Persons do not expect to engage in further communications with the company's board, management, or other shareholders regarding operational, strategic, financial, or governance matters.
Risks
- Significant selling pressure on Innovative Eyewear Inc.'s stock due to the planned divestment of a 16.0% stake by a major shareholder over the next six months.
- Loss of investor confidence stemming from a large shareholder's public declaration that the company no longer represents an attractive investment due to its business prospects and strategy.
- Potential negative perception among other investors and the market regarding the company's future performance and strategic direction.
Future Outlook
The Reporting Persons intend to divest their remaining 16.0% stake in Innovative Eyewear Inc. through open market transactions over the next six months, indicating a complete exit from their investment.
Industry Context
NA
Stakeholder Impact
- Shareholders: Potential for increased selling pressure on the stock as the Reporting Persons liquidate their 16.0% stake.
- Shareholders: Negative signal regarding the company's future prospects and strategy, potentially leading to decreased investor confidence.
Next Steps
- The Reporting Persons plan to divest their remaining 796,007 shares of Common Stock in Innovative Eyewear Inc. through open market transactions over the next six months.
Key Dates
| Date | Description |
|---|---|
| 2024-09-23 | Original Schedule 13D filed |
| 2024-09-23 | Amendment No. 1 to Schedule 13D filed |
| 2024-09-23 | Amendment No. 2 to Schedule 13D filed |
| 2024-09-23 | Amendment No. 3 to Schedule 13D filed |
| 2024-09-24 | Amendment No. 4 to Schedule 13D filed |
| 2024-09-25 | Amendment No. 5 to Schedule 13D filed |
| 2024-10-04 | Amendment No. 6 to Schedule 13D filed |
| 2025-11-06 | Date as of which 5,350,183 shares of Common Stock were outstanding, per Issuer's 10-Q |
| 2025-11-13 | Issuer's Quarterly Report on Form 10-Q for Q3 2025 filed with SEC |
| 2025-12-04 | First reported sale transaction by Reporting Persons |
| 2025-12-10 | Sale transaction by Reporting Persons |
| 2025-12-11 | Sale transaction by Reporting Persons |
| 2025-12-12 | Amendment No. 7 to Schedule 13D filed |
| 2025-12-17 | Sale transaction by Reporting Persons |
| 2025-12-18 | Sale transaction by Reporting Persons |
| 2025-12-19 | Sale transaction by Reporting Persons |
| 2025-12-22 | Sale transaction by Reporting Persons |
| 2025-12-23 | Sale transaction by Reporting Persons |
| 2025-12-24 | Sale transaction by Reporting Persons |
| 2025-12-26 | Date of event requiring filing of this statement; last reported sale transaction by Reporting Persons |
| 2025-12-29 | Joint Filing Agreement signed by Vladimir Galkin and Angelica Galkin |
Recommendation
strong sellA significant shareholder is liquidating their entire 16.0% position in Innovative Eyewear Inc. over the next six months, explicitly stating that the company no longer represents an attractive investment due to its business prospects and strategy. This strong vote of no confidence from a major investor, coupled with the impending selling pressure from their divestment, suggests a highly negative outlook for the stock.
Keywords
Innovative Eyewear Inc, Schedule 13D, beneficial ownership, stock sale, divestment, shareholder activity, investment strategy, market transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.